Encoded Therapeutics

Raised $275M in a Series F round, announced 9 September 2026.

Round

Encoded Therapeutics raised $275 million in Series F funding.

Amount: $275M
Stage: Series F
Announced: 9 September 2026
Lead: GV
Other investors: ARCH Venture Partners, Braidwell LP, Farallon Capital Management, Illumina Ventures, Invus, Janus Henderson Investors, RTW Biotech Opportunities Ltd
Use of funds: Funds ETX101 pivotal and expansion studies in Dravet syndrome alongside commercial scale-up of internal GMP manufacturing facility
Checked: Amount and date checked against the press source

Develops precision genetic medicines for severe neurological disorders as a clinical-stage biotechnology company.

Source: Encoded Therapeutics Raises $275M in Series F Funding - FinSMEs news.google.com
Website: encoded.com ↗

MediaBoost gets your round in front of the press, future hires and your next investors.